TrialDrugs2020

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients.

E Randy Craven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.